Trials / Recruiting
RecruitingNCT07126509
Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma
A Pilot Study of Partial Pleurectomy in Borderline and Unresectable Pleural Mesothelioma
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- University of Chicago · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Purpose of the study: The main purpose of this research study is to see if a surgery procedure (limited partial pleurectomy and decortication) helps symptoms in people who have cancer that is unresectable that might not be able to be removed completely. This is called unresectable cancer. This study will also help the research team learn more about the types of symptoms and quality of life for people who have undergone this surgery, the number of complications following , and the time from surgery to starting other therapy. Th e study team also wants to see see the overall survival of people who have had this procedure as part of their care. What will be done as part of research on this study: * Surgery (Partial Pleurectomy - surgery to remove lining of lungs) * The research team will also ask study participants questions about their symptoms through questionnaires at certain times after surgery. How long this study will last: Participation in this research (pre-surgery, surgery and follow-up) will last for about 2 years. Confidentiality: All personal information will be kept confidential, and data will be used only for research purposes. Contact Information: For more information about this study, please contact PhaseIICRA@medicine.bsd.uchicago.edu
Conditions
- Mesothelioma
- Mesothelioma; Lung
- Mesotheliomas Pleural
- Mesothelioma Malignant Advanced
- Mesothelioma, Malignant
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Partial Pleurectomy | A partial pleurectomy is a surgical procedure where part of the pleura, the lining of the lung cavity, is removed. This may be done to remove tumors, excess tissue, or to treat lung complications. |
Timeline
- Start date
- 2025-12-02
- Primary completion
- 2028-12-01
- Completion
- 2028-12-01
- First posted
- 2025-08-17
- Last updated
- 2026-02-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07126509. Inclusion in this directory is not an endorsement.